Jami S, Helwan A, Tarin T, Aysha M, Mobarak S
Int J Health Sci (Qassim). 2025; 19(1):49-55.
PMID: 39760054
PMC: 11699234.
Livieratos A, Gogos C, Akinosoglou K
Viruses. 2024; 16(8).
PMID: 39205196
PMC: 11359867.
DOI: 10.3390/v16081222.
Arrais M, Dias W, Silva M, Neto L, Pedro N, Jungo S
Afr Health Sci. 2024; 23(4):51-63.
PMID: 38974263
PMC: 11225435.
DOI: 10.4314/ahs.v23i4.9.
Jung M
J Prev Med Public Health. 2024; 57(4):370-378.
PMID: 38938044
PMC: 11309833.
DOI: 10.3961/jpmph.24.196.
Amegashie E, Asamoah P, Ativi L, Adusei-Poku M, Bonney E, Tagoe E
Exp Biol Med (Maywood). 2024; 249:10059.
PMID: 38628843
PMC: 11020089.
DOI: 10.3389/ebm.2024.10059.
[Description of 12 HIV-positive patients who have had the COVID-19 in our area].
Cucurull-Canosa J, Vega-Molpeceres S, Damian-Rodriguez J, Pons-Vinas E
Enferm Infecc Microbiol Clin. 2024; 39(4):208-210.
PMID: 38620716
PMC: 7833341.
DOI: 10.1016/j.eimc.2020.06.014.
Neutralizing antibody response to SARS-CoV-2 bivalent mRNA vaccine in SIV-infected rhesus macaques: Enhanced immunity to XBB subvariants by two-dose vaccination.
Faraone J, Wang X, Qu P, Zheng Y, Vincent E, Xu H
J Med Virol. 2024; 96(3):e29520.
PMID: 38528837
PMC: 10987079.
DOI: 10.1002/jmv.29520.
Mortality Among Persons With HIV in the United States During the COVID-19 Pandemic: A Population-Level Analysis.
Viguerie A, Song R, Bosh K, Lyles C, Farnham P
J Acquir Immune Defic Syndr. 2023; 95(2):126-132.
PMID: 37988697
PMC: 11278038.
DOI: 10.1097/QAI.0000000000003347.
From Emergence to Endemicity: A Comprehensive Review of COVID-19.
Naik R, Avula S, Palleti S, Gummadi J, Ramachandran R, Chandramohan D
Cureus. 2023; 15(10):e48046.
PMID: 37916248
PMC: 10617653.
DOI: 10.7759/cureus.48046.
Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2.
Candel F, Barreiro P, Salavert M, Cabello A, Fernandez-Ruiz M, Perez-Segura P
Viruses. 2023; 15(7).
PMID: 37515137
PMC: 10383267.
DOI: 10.3390/v15071449.
Trends in COVID-19 Vaccine Hesitancy and Uptake Among Persons Living With HIV in Washington, DC.
Castel A, Barth S, Wilbourn B, Horberg M, Monroe A, Greenberg A
J Acquir Immune Defic Syndr. 2023; 94(2):124-134.
PMID: 37368934
PMC: 10529778.
DOI: 10.1097/QAI.0000000000003243.
Seroprevalence of SARS-CoV-2 IgG and associated factors among people living with HIV over the first 12 months following the outbreak of COVID-19 in Burkina Faso, a sub-Saharan African country.
Kabore O, Poda A, Ouattara C, Michodigni F, Belem A, Sawadogo Y
PLoS One. 2023; 18(6):e0286665.
PMID: 37315090
PMC: 10266635.
DOI: 10.1371/journal.pone.0286665.
Double Trouble Co-Infections: Understanding the Correlation Between COVID-19 and HIV Viruses.
Abbasi S, Noor T, Mylavarapu M, Sahotra M, Bashir H, Bhat R
Cureus. 2023; 15(5):e38678.
PMID: 37288215
PMC: 10243673.
DOI: 10.7759/cureus.38678.
Measuring the burden of SARS-CoV-2 infection among persons living with HIV and healthcare workers and its impact on service delivery in Mozambique: protocol of a prospective cohort study.
De Schacht C, Nhacule E, Belo C, Young P, Bhatt N, Junior F
BMJ Open. 2023; 13(6):e068988.
PMID: 37280029
PMC: 10254687.
DOI: 10.1136/bmjopen-2022-068988.
Tenofovir-Containing Antiretroviral Therapy and Clinical Outcomes of SARS-CoV-2 Infection in People Living with HIV.
Rombini M, Cecchini D, Diana Menendez S, Calanni L, Cuini R, Obieta E
Viruses. 2023; 15(5).
PMID: 37243213
PMC: 10223653.
DOI: 10.3390/v15051127.
The Impact of COVID-19 on People Living with HIV-1 and HIV-1-Associated Neurological Complications.
Dutta D, Liu J, Xiong H
Viruses. 2023; 15(5).
PMID: 37243203
PMC: 10223371.
DOI: 10.3390/v15051117.
Assessing and Reassessing the Association of Comorbidities and Coinfections in COVID-19 Patients.
Khan A, El Hosseiny A, Siam R
Cureus. 2023; 15(3):e36683.
PMID: 37113367
PMC: 10126732.
DOI: 10.7759/cureus.36683.
COVID-19 Outcomes in a US Cohort of Persons Living with HIV (PLWH).
Spence A, Desale S, Lee J, Kumar P, Huang X, Cooper S
Reports (MDPI). 2023; 5(4).
PMID: 37063094
PMC: 10104440.
DOI: 10.3390/reports5040041.
HIV and COVID-19 Co-Infection: Epidemiology, Clinical Characteristics, and Treatment.
Basoulis D, Mastrogianni E, Voutsinas P, Psichogiou M
Viruses. 2023; 15(2).
PMID: 36851791
PMC: 9962407.
DOI: 10.3390/v15020577.
COVID-19 mortality in patients with immunodeficiency and its predictors: a systematic review.
SeyedAlinaghi S, Karimi A, Barzegary A, Mojdeganlou H, Vahedi F, Mirghaderi S
Eur J Med Res. 2022; 27(1):195.
PMID: 36209202
PMC: 9547631.
DOI: 10.1186/s40001-022-00824-7.
